Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03CUF
|
||||
| Former ID |
DAP000993
|
||||
| Drug Name |
Furazolidone
|
||||
| Synonyms |
Bifuron; Corizium; Coryzium; Diafuron; Enterotoxon; Furall; Furaxon; Furaxone; Furazol; Furazolidine; Furazolidon; Furazolidona; Furazolidonum; Furazolum; Furazon; Furidon; Furovag; Furox; Furoxal; Furoxane; Furoxon; Furoxone; Furozolidine; Giardil; Giarlam; Medaron; Neftin; Nicolen; Nifulidone; Nifuran; Nifurazolidone; Nifurazolidonum; Nitrofurazolidone; Nitrofurazolidonum; Nitrofuroxon; Optazol; Ortazol; Puradin; Roptazol; Sclaventerol; Tikofuran; Topazone; Trichofuron; Tricofuron; Tricoron; Trifurox; Viofuragyn; Fiurox aerosol powder; Furoxone Liquid; Furoxone Swine Mix; NF 180 custom mix ten; F-8900; Furazolidona [INN-Spanish]; Furazolidone [INN:BAN]; Furazolidonum [INN-Latin]; Furox Aerosol Powder (Veterinary); Furoxone (TN); NF-180; Usaf ea-1; Dependal-M (TN); Furazolidone (USP/INN); N-(5-Nitro-2-furfurylidene)-3-amino-2-oxazolidone; N-(5-Nitro-2-furfurylidene)-3-aminooxazolidine-2-one; 3-(((5-Nitro-2-furanyl)methylene)amino)-2-oxazolidinone; 3-((5-Nitrofurfurylidene)amino)-2-oxazolidinone; 3-((5-Nitrofurfurylidene)amino)-2-oxazolidone; 3-((5-Nitrofurylidene)amino)-2-oxazolidone; 3-(5'-Nitrofurfuralamino)-2-oxazolidone; 3-(5-Nitrofurfurylideneamino)-2-oxazolidinone; 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidinone; 3-[(5-Nitrofurfurylidene)amino]-2-oxazolidone; 3-[(5-Nitrofurylidene)amino]-2-oxazolidone; 3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one; 3-[[(5-Nitro-2-furanyl)methylene]amino]-2-oxazolidinone; 3-{[(5-Nitro-2-furanyl)methylene]amino}-2-oxazolidinone; 3-{[(5-nitro-2-furyl)methylene]amino}-1,3-oxazolidin-2-one; 3-{[(E)-(5-nitrofuran-2-yl)methylidene]amino}-1,3-oxazolidin-2-one; 5-Nitro-N-(2-oxo-3-oxazolidinyl)-2-furanmethanimine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Diarrhea [ICD9: 787.91; ICD10:A09, K59.1] | Approved | [538445] | ||
| Therapeutic Class |
Antiinfective Agents
|
||||
| Company |
GlaxoSmithKline
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C8H7N3O5
|
||||
| Canonical SMILES |
C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-]
|
||||
| InChI |
1S/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5+
|
||||
| InChIKey |
PLHJDBGFXBMTGZ-WEVVVXLNSA-N
|
||||
| CAS Number |
CAS 67-45-8
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
10200, 72440, 602746, 7847895, 8000339, 8139923, 8149352, 10532427, 11058827, 15220531, 24870024, 24894997, 26611752, 26679646, 26749310, 29215179, 39296723, 47275491, 47424181, 47646502, 48018845, 48094488, 48243304, 48393877, 49699022, 49747527, 50001677, 50085998, 50107562, 50107563, 52074133, 53786873, 57361168, 57650761, 58025007, 81040775, 81093031, 85240169, 85787354, 85789182, 88484924, 92124226, 92307333, 92711038, 93166340, 99301173, 103304486, 106225507, 114181310, 124526348
|
||||
| ChEBI ID |
ChEBI:5195
|
||||
| SuperDrug ATC ID |
G01AX06
|
||||
| SuperDrug CAS ID |
cas=000067458
|
||||
| Target and Pathway | |||||
| Target(s) | Bacterial DNA | Target Info | Modulator | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.